Land: Nya Zeeland
Språk: engelska
Källa: Medsafe (Medicines Safety Authority)
Levobunolol hydrochloride 0.5%{relative}; ; ;
AbbVie Limited
Levobunolol hydrochloride 0.5% w/v
0.5 %
Eye drops, solution
Active: Levobunolol hydrochloride 0.5%{relative} Excipient: Benzalkonium chloride Dibasic sodium phosphate heptahydrate Disodium edetate Hydrochloric acid Monobasic potassium phosphate Polyvinyl alcohol Purified water Sodium chloride Sodium hydroxide Sodium metabisulfite
Bottle, dropper, 1x5mL, 5 mL
Prescription
Prescription
Piramal Enterprises Limited
Package - Contents - Shelf Life: Bottle, dropper, - 5 mL - 24 months from date of manufacture stored at or below 25°C protect from light 4 weeks opened stored at or below 25°C protect from light
1985-12-05
1 BETAGAN ® EYE DROPS 0.5% (LEVOBUNOLOL HYDROCHLORIDE 5 MG PER ML) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about BETAGAN ® eye drops, including how to use the eye drops. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using BETAGAN ® eye drops against the benefits they expect it will have for you. If you have any concerns about using this medicine, ask your doctor or pharmacist. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT BETAGAN ® EYE DROPS ARE USED FOR BETAGAN ® eye drops are a beta blocking agent used to lower increased pressure in the eye. Your doctor has prescribed BETAGAN ® eye drops to control increased pressure in the eye or to treat an acute increase in pressure that can occur after eye operations. Sometimes your doctor may give you another medicine or eye drop as well as BETAGAN ® eye drops to help you. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye. There are usually no symptoms of glaucoma. The only way of knowing that you have glaucoma is to have your eye pressure, optic nerve and visual field checked by an eye specialist or optometrist. If glaucoma is not treated it can lead to serious problems, including total blindnes Läs hela dokumentet
BETAGAN ® 5% levobunolol hydrochloride Datasheet Version 3.0 DATA SHEET 1. PRODUCT NAME BETAGAN ® 5mg/mL eye drops 2. QUALITATIVE AND QUANTITATIVE COMPOSITION levobunolol hydrochloride 5mg/mL For full list of excipients, see section 6.1 List of Excipients. 3. PHARMACEUTICAL FORM Clear, colourless to slightly yellow, sterile ophthalmic solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Control of intraocular pressure in patients with open angle glaucoma. Control of ocular hypertension. Treatment of acute increased intraocular pressure following laser capsulotomy and extra-capsular cataract extraction. 4.2 DOSAGE AND METHOD OF ADMINISTRATION The recommended dose is one drop of BETAGAN ® 0.5% eye drops in the affected eye(s) twice a day. Studies have also shown that IOP is controlled in many patients with one drop of BETAGAN ® 0.5% eye drops in the affected eye(s) once a day. Careful monitoring of patients is advised, particularly in the first few days after starting treatment or if the dose of BETAGAN ® eye drops is increased. Dosages above one drop of BETAGAN ® 0.5% eye drops twice daily are not generally more effective. If the patient's IOP is not at a satisfactory level on this regimen, concomitant therapy with dipivefrine and/or adrenaline, and/or pilocarpine and other miotics, and/or systemically administered carbonic anhydrase inhibitors, such as acetozolamide, can be instituted. In order to minimise systemic absorption of BETAGAN ® eye drops, apply pressure to the tear duct immediately following administration of the drug._ _ PAEDIATRIC POPULATION Safety and effectiveness in children have not been established. 4.3 CONTRAINDICATIONS BETAGAN ® eye drops are contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma or severe chronic obstructive pulmonary disease (see 4.4 Special Warnings and Precautions for use); sinus bradycardia; sick sinus syndrome (including sino-atrial nodal block); second or third degree atrioventricular block not controlled with a Läs hela dokumentet